Bridger Management’s Lifestance Health LFST Stock Holding History

Bridger Management’s Portfolio LFST Stock Details LFST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-389,700	Closed	-$2.6M	–	30
2025 Q1	$2.6M	Buy	+389,700	New	+$2.96M	1.29%	20

Other funds holding LFST

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Summit Partners Boston, Massachusetts $670M AUM 6.71% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bridger Management's LFST Position: Q2 2025 in Review

Bridger Management sold out of Lifestance Health (LFST) in Q2 2025, closing a stake of 389,700 shares — an estimated $2.6M sold.

Bridger Management first reported a position in LFST in Q1 2025 and held it in 1 quarter. The position peaked at $2.6M in Q1 2025. 194 funds tracked by Wall St. Rank hold LFST as of Q2 2025.

Bridger Management reported no remaining Lifestance Health position as of Q2 2025 after selling out during the quarter.
Bridger Management sold 389,700 Lifestance Health shares in Q2 2025, an estimated $2.6M.
Bridger Management first reported a position in Lifestance Health in Q1 2025 and held it in 1 quarter.
Bridger Management's Lifestance Health position peaked at $2.6M in Q1 2025.
194 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2025.

Based on Bridger Management's 13F filing for Q2 2025, filed 11 Aug 2025.